Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: w0z who wrote (12735)	1/13/2022 6:27:45 PM
From: TigerPaw	1 Recommendation Recommended By Trader77 Read Replies (1) \| Respond to of 26788

You mean Pfizer's vax testing? There had been a lot of testing of the MRNA concept and base structure. What Pfizer and Moderna were testing was the covid specific modifications. The delivery mechanism had already been tested, so the only thing necessary was to test if the little fragments of virus spikes which are supposed to stimulate antibodies, actually stimulated antibodies. It's a vaccine not a cure, so it didn't take much time to inject people and then test their blood for antibodies. They found antibodies, and the patients didn't die from some unknown side effect, so what else was there to study? It's not like they would have a control group that gets an injection that does nothing and then test to see that nothing had happened (that was the kind of tests that already had been done on the delivery platform long before covid has been seen). Your concept of what needed to be tested is seriously flawed.